首页 | 本学科首页   官方微博 | 高级检索  
     


Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris
Affiliation:1. Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;2. Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University (CMU), Chiang Mai, Thailand;3. Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA;4. Ronald O. Perelman Department of Dermatology, NYU Grossman School of Medicine, New York University Langone Health, New York City, New York, USA
Abstract:
><ol class=
  • Download : Download high-res image (294KB)
  • Download : Download full-size image
  • Keywords:CR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0015"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  complete remission  CROT"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0025"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  complete remission off oral systemic therapy  DSG"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0035"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  desmoglein  PDAI"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0045"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  Pemphigus Disease Area Index  PV"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0055"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  pemphigus vulgaris  RA"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0065"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  rheumatoid arthritis  RTX1"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0075"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  first rituximab cycle  RTX2"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0085"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  second rituximab cycle
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号